Skip to main content
Log in

Atrial Fibrillation Ablation in Octogenarians: Where Do We Stand?

  • Invasive Electrophysiology and Pacing (J Singh, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

The prevalence of atrial fibrillation increases significantly with age, affecting nearly 10 % of adults greater than 80 years of age. Complications from atrial fibrillation, including stroke, also increase with age. Medical therapy includes anticoagulation, ventricular rate control, and if symptoms persist, maintenance of sinus rhythm with antiarrhythmic drugs. However, anticoagulation and antiarrhythmic therapy is often challenging in the elderly due to side effects, comorbidities, and heightened sensitivity to medications. Catheter based ablation of atrial fibrillation is an effective treatment for paroxysmal atrial fibrillation. However, the major randomized controlled trials, such as Thermocool AF and STOP-AF studies, have excluded the elderly patients. Current guidelines suggest caution when considering ablation for elderly patients due to a lack of available data. We will review recent studies that have observed the outcomes of atrial fibrillation ablation in the elderly, specifically those studies that included octogenarians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest have been highlighted as: • Of importance •• Of major importance

  1. Williams E, Hall B, Traub D, Bahnson T, Hranitzky P, Zareba W, et al. Catheter ablation of atrial fibrillation in elderly. Curr Opin Cardiol. 2011;26:25–9.

    Article  PubMed  Google Scholar 

  2. Sankaranarayanan R, Kirkwood G, Dibb K, Clifford G. Comparison of atrial fibrillation in the young vs that in elderly: a review. Cardiol Res Pract. 2013;2012:1–16.

    Article  Google Scholar 

  3. Marinigh R, Lip GH, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010;56:827–37.

    Article  PubMed  Google Scholar 

  4. •• Santangeli P, Biase L, Mohanty P, Burkhardt D, Horton R, Bai R, et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J Cardiovasc Electrophysiol. 2012;23:687–93. Comparison of AF ablation outcomes based on AF type between younger (<80 years) and older (>80 year) patients.

    Article  PubMed  Google Scholar 

  5. Coppens M, Eikelboom J, Hart R, Yusuf S, Lip G, Dorian P, et al. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J. 2013;34:170–6.

    Article  PubMed  CAS  Google Scholar 

  6. Traub D, Daubert J, McNitt S, Zareba W, Hall B. Catheter ablation of atrial fibrillation in the elderly: where do we stand? Cardiol J. 2009;16:113–20.

    PubMed  Google Scholar 

  7. Ruskin JN. The cardiac arrhythmia suppression trial (CAST). N Engl J Med. 1988;321:386–8.

    Article  Google Scholar 

  8. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med. 2007;356:935–41.

    Article  PubMed  CAS  Google Scholar 

  9. • Calkins H, Kuck K, Cappato R, Brugada J, Camm J, Chen S, et al. HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research. Hear Rhythm. 2012;2012(9):632–96. These are the latest guidelines for treating atrial fibrillation with catheter ablation.

    Article  Google Scholar 

  10. Corrado A, Patel D, Riedlbauchova L, Fahmy T, Themistoclakis S, Bonso A, et al. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. J Cardiovasc Electrophysiol. 2008;19:807–11.

    Article  PubMed  Google Scholar 

  11. • Zado E, Callans D, Riley M, Hutchinson M, Garcia F, Bala, et al. Long–term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2008;19:621–6. Large retrospective study of AF ablation in elderly patients compared with younger groups.

    Article  PubMed  Google Scholar 

  12. Wilber D, Pappone C, Neuzil P, Paola A, Marchlinski F, Natale A, et al. Thermocool AF trial investigators: comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303:333–40.

    Article  PubMed  CAS  Google Scholar 

  13. Packer DL, Irwin JM, Champagne J, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front STOP-AF clinical trial. Atlanta: American College of Cardiology Annual Scientific Section; 2010.

    Google Scholar 

  14. • Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, et al. Long–term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol. 2010;33:146–52. Large retrospective study of AF ablation in elderly patients compared with younger groups.

    Article  PubMed  Google Scholar 

  15. Shah R, Freeman J, Shilane D, Wang P, Go A, Hlatky M. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012;59:143–9.

    Article  PubMed  Google Scholar 

  16. Lim T, Day J, Weiss P, Crandall B, May H, Bair T, et al. More aggressive left atrial ablation in elderly patients does not increase procedural complications and favorably impacts outcomes. J Card Rhythm Manage. 2011;2:206–11.

    Google Scholar 

  17. Wann L, Curtis A, January CT, Ellenbogen K, Lowe J, Estes M, et al. ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;57:223–42.

    Article  PubMed  Google Scholar 

  18. Epstein E, Vidaillet H, Greene L, Curtis B, Ellenbogen A, Simmons T, et al. Frequency of symptomatic atrial fibrillation in patients enrolled in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. J Cardiovasc Electrophysiol. 2002;13:667–71.

    Article  PubMed  Google Scholar 

Download references

Compliance with ethics Guidelines

Conflict of Interest

Gevorg Stepanyan declares that he has no conflict of interest.

Edward P. Gerstenfeld has received grant support from Rhythmia Medical, Biosense Webster; and has received honoraria from Medtronic, Biosense Webster, St. Jude Medical, and Voyage Medical.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward P. Gerstenfeld.

Additional information

This article is part of the Topical Collection on Invasive Electrophysiology and Pacing

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stepanyan, G., Gerstenfeld, E.P. Atrial Fibrillation Ablation in Octogenarians: Where Do We Stand?. Curr Cardiol Rep 15, 406 (2013). https://doi.org/10.1007/s11886-013-0406-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-013-0406-y

Keywords

Navigation